Literature DB >> 27394406

Multimodal analgesia: A systematic review of local NSAIDs for non-ophthalmologic postoperative pain management.

Lisa Brubaker1, Lauren Kendall2, Eva Reina3.   

Abstract

INTRODUCTION: While the analgesic benefits of systemically administered non-steroidal anti-inflammatory drugs (NSAIDs) for postoperative pain are well established, benefits of locally administered NSAIDs remain unclear outside the field of ophthalmologic surgery. Studies of local NSAID administration for postoperative analgesia vary considerably in terms of dosing and methodologic quality, making it difficult to derive clinically useful information. The primary objective of this systematic review is to summarize the currently available literature in order to assess the value of local NSAIDs as a component of the multimodal postoperative pain management regimen.
METHODS: A comprehensive search of PubMed and CENTRAL identified twelve randomized controlled trials comparing the use of local NSAIDs to systemic NSAIDs and/or placebo for postoperative multimodal pain management in patients undergoing non-ophthalmologic surgery. Nine trials met eligibility criteria (n = 532); each trial was classified into a subgroup based on time of NSAID administration (pre- or postoperatively) and comparison group (systemic NSAID or placebo). A frequency analysis was performed for similar outcomes reported in two or more studies. The risk of bias for each outcome and quality of evidence were assessed utilizing the Cochrane Risk of Bias instrument and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology, respectively.
RESULTS: Low to moderate quality evidence exists indicating that pre- or postoperative administration of local NSAIDs may provide adequate postoperative analgesia within a multimodal regimen. Additional across-study analysis reveals clinically important but non-statistically significant trends towards a decreased use of additional analgesics during the postoperative period. The risk of adverse effects secondary to local NSAID administration is low.
CONCLUSIONS: Local NSAIDs may be effective agents in the multimodal postoperative analgesia regimen. However, small sample size and methodologic variability across trials limits power and generalizability of outcomes. Further high quality studies are required. SYSTEMATIC REVIEW REGISTRATION NUMBER: CRD42016038464.
Copyright © 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Analgesia: local NSAIDs; Multimodal; Pain: postoperative

Mesh:

Substances:

Year:  2016        PMID: 27394406     DOI: 10.1016/j.ijsu.2016.07.003

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  5 in total

1.  Gaps in standardized postoperative pain management quality measures: A systematic review.

Authors:  Jennifer M Joseph; Davide Gori; Catherine Curtin; Jennifer Hah; Vy Thuy Ho; Steven M Asch; Tina Hernandez-Boussard
Journal:  Surgery       Date:  2021-09-15       Impact factor: 3.982

2.  Utilization and effectiveness of multimodal discharge analgesia for postoperative pain management.

Authors:  Karishma Desai; Ian Carroll; Steven M Asch; Tina Seto; Kathryn M McDonald; Catherine Curtin; Tina Hernandez-Boussard
Journal:  J Surg Res       Date:  2018-04-11       Impact factor: 2.192

3.  Two New βN-Alkanoyl-5-Hydroxytryptamides with Relevant Antinociceptive Activity.

Authors:  Jorge Luis Amorim; Fernanda Alves Lima; Ana Laura Macedo Brand; Silvio Cunha; Claudia Moraes Rezende; Patricia Dias Fernandes
Journal:  Biomedicines       Date:  2021-04-22

Review 4.  Postoperative Multimodal Pain Management and Opioid Consumption in Arthroscopy Clinical Trials: A Systematic Review.

Authors:  Ryan W Paul; Patrick F Szukics; Joseph Brutico; Fotios P Tjoumakaris; Kevin B Freedman
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-12-17

5.  Risk factors predicting less favorable outcomes in endoscopic lumbar discectomies.

Authors:  Jeffrey L Katzell
Journal:  J Spine Surg       Date:  2020-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.